1. Home
  2. BEAM vs HOG Comparison

BEAM vs HOG Comparison

Compare BEAM & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$29.63

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$28.36

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
HOG
Founded
2017
1903
Country
United States
United States
Employees
N/A
6400
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
BEAM
HOG
Price
$29.63
$28.36
Analyst Decision
Buy
Hold
Analyst Count
12
7
Target Price
$50.75
$24.00
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
3.05%
EPS Growth
82.31
N/A
EPS
N/A
0.97
Revenue
$24,000.00
$4,473,175,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$33.77
$3.79
P/E Ratio
N/A
$28.19
Revenue Growth
33.33
N/A
52 Week Low
$19.36
$17.09
52 Week High
$38.26
$31.25

Technical Indicators

Market Signals
Indicator
BEAM
HOG
Relative Strength Index (RSI) 51.16 52.01
Support Level $28.40 $24.09
Resistance Level $31.98 $28.71
Average True Range (ATR) 1.49 0.82
MACD 0.14 -0.08
Stochastic Oscillator 54.56 29.76

Price Performance

Historical Comparison
BEAM
HOG

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

Share on Social Networks: